Sign in to your account
or
By signing in you agree to our
Terms & conditions
 and 
Privacy policy
Sku Image
Sku Image
sold out tag

Kadcyla 160mg Injection

Ado-trastuzumab emtansine (160mg)
Genuine
Authenticity Assured
Prescription
required
Cold stored
Stored between 2-8°C
Kadcyla 160mg Injection is used in the treatment of early as well as metastatic breast cancer. It is used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines.

Written By Dr. Sakshi Jain, MS, BDS,
Reviewed By Dr. Mekhala Chandra, MD, MBBS,
Last updated on 26 Aug 2026 | 01:02 AM (IST)
₹210017 MRP ₹23337810% off 
 
 
0
footer-icon

Save more with additional offers

offer icon
Assured cashback up to ₹300*. T&C Apply*
Assured cashback up to ₹300*. T&C Apply*
chevron icon
offer icon
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Assured cashback up to ₹300*. T&C Apply*
Assured cashback up to ₹300*. T&C Apply*
chevron icon
offer icon
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
Get up to ₹75 cashback on a minimum order value (MOV) of ₹499 and above, valid once per customer.
chevron icon
offer icon
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.
chevron icon
offer icon
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.
chevron icon

General Information

Contains

Ado-trastuzumab emtansine (160mg)

Marketer

Roche Products India Pvt Ltd

Storage

Store in a refrigerator (2 - 8°C). Do not freeze.
The content is shown in English
Kadcyla 160mg Injection image
Kadcyla 160mg Injection image

Product introduction

Kadcyla 160mg Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include tiredness, nausea, musculoskeletal (bone, muscle or joint) pain, and bleeding. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

There is a Patient Support Program/Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Uses of Kadcyla Injection

Benefits of Kadcyla Injection

Breast cancer
Kadcyla 160mg Injection helps to treat initial stages of breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Metastatic breast cancer
Kadcyla 160mg Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Kadcyla 160mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.

Side effects of Kadcyla Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Kadcyla
  • Tiredness
  • Nausea
  • Musculoskeletal (bone, muscle or joint) pain
  • Headache
  • Constipation
  • Diarrhea
  • Chills
  • Insomnia (difficulty in sleeping)
  • Jaundice
  • Bleeding disorder
  • Vomiting
  • Abdominal pain
  • Nerve damage
  • Dryness in mouth
  • Mouth swelling
  • Flu-like symptoms
  • Decreased potassium level in blood
  • Decreased red blood cell count

How to use Kadcyla Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Kadcyla Injection works

Kadcyla 160mg Injection is an anti-cancer medicine. It binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.

Quick tips

  • Kadcyla 160mg Injection is given via a drip into a vein (intravenous infusion) under the supervision of a doctor.
  • Do not skip any dose and complete the course as suggested by your doctor.
  • Your doctor may check your liver function before starting treatment and regularly thereafter. Inform your doctor if you notice yellowing of eyes or skin, dark urine, or stomach pain.
  • Women who could get pregnant should use a reliable method of contraception to prevent pregnancy while taking this medicine.
  • Regular monitoring of heart function (tests like echocardiogram) and blood tests to monitor the level of blood cells may be advised before starting treatment and regularly during treatment with Kadcyla 160mg Injection.

Safety advice

Alcohol

Alcohol

CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Kadcyla 160mg Injection. Please consult your doctor.
Pregnancy

Pregnancy

UNSAFE
Kadcyla 160mg Injection is highly unsafe during pregnancy. It can cause serious harm to the unborn baby, including birth defects and pregnancy loss. Do not use this medicine if you are pregnant or planning to become pregnant.
Breast feeding

Breast feeding

UNSAFE
Kadcyla 160mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving

Driving

UNSAFE
Kadcyla 160mg Injection may decrease alertness, affect your vision, or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney

Kidney

CONSULT YOUR DOCTOR
There is limited data available on the use of Kadcyla 160mg Injection in patients with kidney disease. Please consult your doctor.
Liver

Liver

CAUTION
Kadcyla 160mg Injection should be used with caution in patients with liver disease. Dose adjustment may be needed.

Frequently asked questions

Kadcyla 160mg Injection is used to treat HER2-positive breast cancer that has spread to other parts of the body (metastatic breast cancer) after prior treatment with trastuzumab and a taxane.
Kadcyla 160mg Injection is a conjugate of the HER2 directed trastuzumab and a highly toxic microtubule-targeted drug (emtansine). Thus it is made up of 2 cancer-fighting agents in 1 medicine- The monoclonal antibody trastuzumab and a chemotherapy emtansine. Kadcyla 160mg Injection brings chemotherapy medicine (emtansine) into HER2-positive cells and kills them. It is designed to cause less harm to normal cells.

Fact Box

Chemical Class

Peptides

Habit Forming

No

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Anti-HER2 Monoclonal Antibody
Related ayurvedic ingredients
100% genuine products
100% genuine products
Safe & secure payments
Safe & secure payments
No contact delivery
No contact delivery
Fully sanitized facilities
Fully sanitized facilities

User feedback

Breast cancer
100%
Excellent
67%
Average
33%
Nausea
50%
Low blood platelets
50%
<h3 class=titleMediumExtraBold>Want to know more</h3>

Want to know more

We provide you with authentic, trustworthy and relevant information
<h3 class=titleMediumExtraBold>Have issue with the content</h3>

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Roche Products India Pvt Ltd
Address: 1503, 15th Floor, ‘The Capital’, Plot no. C-70, Behind ICICI Bank, BKC, Bandra (E) , Mumbai 400051

Vendor Details

Country of origin: India
Why we need a prescription?
Cold chain description image
close sheet